Research News

Open bottles and opioid pills strewn on a table.
  • Multipronged approach needed to stem synthetic opioid deaths
    7/11/24

    Pharmacy professor Edward Bednarczyk discusses an online training program for prescribers and other efforts.

  • New study probes macrophages’ role in pulmonary fibrosis
    4/16/24

    These white blood cells promote scar tissue formation, but certain drugs, such as pirfenidone, may stop this from happening.

  • Nouh named fellow of ASME
    4/15/24

    The UB engineer is being recognized for his distinguished research contributions to the mechanical engineering field and dedicated service to the society.

  • UB startup Abceutics Inc. acquired by Merck
    4/12/24

    The acquisition includes a novel platform technology designed to improve the safety and efficacy of an important emerging class of cancer medicines.

  • Time to rethink school discipline
    4/11/24

    A UB study found that young adults with a history of school discipline report depressive symptoms and lower well-being.

  • Conveying research through imagery
    4/5/24

    The Art of Research competition highlights the work of UB graduate students through visually captivating images and engaging captions.

  • Copprium moves its tech closer to marketplace with UB’s assistance
    4/5/24

    The conductive ink startup was spun out from the university’s Business and Entrepreneur Partnerships office.

  • Des Forges symposium set for April 16
    4/4/24

    The conference held in memory of the human rights advocate will focus on sexual and reproductive rights from a human rights perspective.

  • UB geoscientists to help photograph eclipse for NASA
    4/4/24

    Citizen science teams across the path of totality will take advantage of a rare opportunity to observe the sun’s atmosphere.

  • NSF director trades AI knowledge with UB community
    4/4/24

    Sethuraman Panchanathan learned plenty about UB’s research — and also offered plenty of advice — during a visit to campus.

  • JAMA paper shows telemedicine success for HCV treatment
    4/4/24

    In people with opioid use disorder, telemedicine treatment for hepatitis C virus was more than twice as successful as off-site referral.